Biofrontera Inc. (BFRI)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$1.12
-0.88%
Mkt Cap $9.60M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 19, 2026 | $16.15M | $17.10M | +5.88% | $0.29 | $0.50 | +72.41% | — | — |
| Q4 2025 Nov 12, 2025 | $16.15M | $6.99M | -56.72% | -$0.60 | -$0.59 | +1.67% | — | — |
| Q3 2025 Aug 13, 2025 | $9.55M | $9.03M | -5.45% | -$0.45 | -$0.57 | -26.67% | — | — |
| Q2 2025 May 15, 2025 | $10.55M | $8.59M | -18.60% | -$0.14 | -$0.47 | -235.71% | — | — |
| Q1 2025 Mar 21, 2025 | $10.50M | $12.55M | +19.53% | $0.02 | -$2.33 | -11750.00% | — | — |
| Q4 2024 Nov 13, 2024 | $10.01M | $9.01M | -9.97% | -$0.73 | -$0.86 | -17.81% | — | — |
| Q3 2024 Aug 14, 2024 | $8.21M | $7.84M | -4.52% | -$1.19 | -$1.12 | +5.88% | — | — |
| Q2 2024 May 15, 2024 | $10.86M | $7.90M | -27.25% | -$1.63 | -$1.85 | -13.50% | — | — |
| Q1 2024 Mar 15, 2024 | $11.81M | $10.60M | -10.28% | -$1.19 | -$2.33 | -95.80% | — | — |
| Q4 2023 Nov 9, 2023 | $12.44M | $8.88M | -28.63% | -$4.23 | -$4.64 | -9.69% | — | — |
| Q3 2023 Aug 11, 2023 | $6.20M | $5.85M | -5.68% | -$5.14 | -$6.14 | -19.46% | — | — |
| Q2 2023 May 12, 2023 | $9.15M | $8.73M | -4.56% | -$4.40 | -$4.40 | +0.00% | — | — |
| Q1 2023 Mar 13, 2023 | $7.03M | $10.14M | +44.30% | -$2.60 | -$2.80 | -7.69% | — | — |
| Q4 2022 Nov 14, 2022 | $9.15M | $4.32M | -52.77% | -$6.40 | -$4.60 | +28.13% | — | — |
| Q3 2022 Aug 12, 2022 | $4.55M | $4.46M | -2.04% | -$6.20 | -$8.80 | -41.94% | — | — |
| Q2 2022 May 13, 2022 | $9.83M | $9.75M | -0.82% | -$2.80 | -$1.60 | +42.86% | — | — |
| Q2 2022 Apr 8, 2022 | $9.24M | $9.17M | -0.75% | -$3.60 | -$8.40 | -133.33% | — | — |
| Q4 2021 Nov 30, 2021 | $4.86M | $4.33M | -10.77% | -$11.60 | -$10.20 | +12.07% | — | — |
| Q4 2021 Nov 1, 2021 | — | $5.86M | — | — | -$0.01 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | $4.74M | — | — | -$0.01 | — | — | — |